Week in Review: Drug Prices in Television and Survey Finds Communication Gap with BV

This weekly video program provides our readers with an in-depth review of the latest news, medical product approvals, FDA rulings, and more. The Week in Review highlights aContemporary Clinicarticle each week, and is a can't miss for the busy healthcare professional.

Nicole Grassano, Host:Hello and welcome to thePharmacy TimesNews Network. I’m Nicole Grassano your host for our Pharmacy Week in Review.

Officials with the Centers for Medicare & Medicaid Services this week proposed a requirement that prescription drug manufacturers post the Wholesale Acquisition Cost for drugs covered in Medicare or Medicaid in direct-to-consumer television advertisements,Pharmacy Timesreported. U.S. Department of Health and Human Services Secretary Alex Azar announced the plan during a speech at the National Academy of Medicine.

Officials with the Pharmaceutical Research and Manufacturing Association said in a statement that they plan to request member companies’ direct-to-consumer television advertisements to direct patients to information about medicine costs, including the list price of the medicine, out-of-pocket costs or other context about the potential cost of the medicine and available financial assistance. Association officials said that the biopharmaceutical industry will also launch a platform that will provide patients, caregivers, and providers with cost and financial assistance information for brand-name medicines, as well as other patient support resources.

The results of an online survey indicate a significant disconnect in communication between patients and providers regarding bacterial vaginosis, or BV,Contemporary Clinicreported. BV affects 21 millionwomeneach year in the United States and is one of the most prevalent gynecologic infections.

According to the survey results, further education is needed to bridge the gap in communication and would help women to obtain diagnosis and treatment initiation sooner. Although 63% of surveyed patients said that their health care providers discussed general information about BV, just 34% said that they discussed the risks associated with BV if left untreated.

Conducted by Lupin Pharmaceuticals in a partnership with the American Sexual Health Association and the National Association of Nurse Practitioners inWomen’s Healththe survey and its results were presented last week, during the NPWH Premier Women’s Health Conference in San Antonio, Texas.

Obesity and weight gain in early adulthood may be associated with an increased risk of early-onset colorectal cancer or CRC in women under the age of 50, according to a new study published in JAMA Oncology and reported on bySpecialty Pharmacy Times. In the United States, CRC incidence and mortality among younger adults has been steadily increasing for reasons unknown.

The study investigators aimed to determine whether obesity and weight gain could be potential contributors to an increased risk of early-onset CRC in this population. According to the study results, women with the highest body mass index, defined as a BMI greater than 30, had almost twice the risk of early-onset CRC compared with women with the lowest BMIs, defined as 18.5 to 22.9.

Pharmacists may get more questions about DiaResQ if their patients have seen a new commercial for the OTC medication.

In the spot, called “Over the Moon,” an astronaut on the moon tells Houston that he has a problem. It isn’t malfunctioning equipment, however, but an unexpected bout of lunar diarrhea. According to the commercial, DiaResQ offers relief from such unwanted adventures.

For more great coverage and practical information for today’s pharmacist, visit our website and sign up for our Daily eNews. And don’t forget to follow us on Facebook, Twitter, and Instagram.

Thanks for watching our Pharmacy Week in Review. I’m Nicole Grassano at thePharmacy TimesNews Network.

FollowContemporary Clinic onLinkedIn,FacebookandTwitter.